Use this dropdown to select your preferred language.
We have been transforming lives in healthcare since 1885. Our 53,000 employees in 130 markets create value through innovation by infusing long-term, sustainable thinking into our Human Pharma and Animal Health units.
We acknowledge the deep and complex ways the lives of humans and animals are interconnected and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.
Nippon Boehringer Ingelheim Co., Ltd. is a leading pharmaceutical company in Japan, dedicated to the research, development, manufacture, and marketing of innovative healthcare products. As part of the global Boehringer Ingelheim group, it focuses on improving human and animal health through breakthrough therapies and sustainable solutions.
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture.
Boehringer Ingelheim Middle East & North Africa
Pharmaceutical Company
please use the eps logo as the png logo is cropped and not full
EG LABO, filiale française de STADA est un acteur majeur de la Santé. Avec 3 domaines de portefeuille, les Génériques, les Spécialités dont les Biosimilaires et la santé Grand Public grâce à ses gammes reconnues par les professionnels et les patients (Synthol®, Mitosyl®, Bronchokod® …), EG Labo poursuit sa mission de Prendre Soin de la Santé de tous.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in four therapy areas – Oncology, Cardiovascular, Renal & Metabolism and Respiratory and Rare Disease. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date.
* The company description for this page is added by the organisation and is not written by Top Employers Institute.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.
As a leading research-driven biopharmaceutical company Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. The Regional Center Vienna is responsible for the business in Austria and more than thirty countries in Central and Eastern Europe and Central Asia, as well as Switzerland and Israel and is also the group’s main cancer research site.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, we create value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, we take a long-term perspective. Around 52,000 employees serve more than 130 markets in Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885, family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in Human Pharma and Animal Health.